Lexaria Bioscience Corp. (LEXX)
0.7011
-0.03
(-4.08%)
USD |
NASDAQ |
Jan 16, 12:21
Lexaria Bioscience Market Cap: 17.45M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 109.22M |
| Aurinia Pharmaceuticals, Inc. | 1.976B |
| Edesa Biotech, Inc. | 9.982M |
| Xenon Pharmaceuticals, Inc. | 3.145B |
| ProMIS Neurosciences, Inc. | 17.86M |
Market Cap Related Metrics
| PS Ratio | 25.77 |
| PEG Ratio | -0.0702 |
| Price to Book Value | 3.552 |
| Price | 0.7011 |
| Earnings Yield | -81.93% |
| PEGY Ratio | -0.0702 |